Livsmed Inc (KOSDAQ:491000)
South Korea · Delayed Price · Currency is KRW 41,300
+700 (1.72%)
At close: Jun 12, 2026
Livsmed Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | -22,459 | -22,874 | -25,585 | -57,021 | -59,019 |
Depreciation & Amortization | 3,115 | 2,734 | 1,647 | 1,035 | 728.17 |
Loss (Gain) From Sale of Assets | - | - | - | -0.99 | - |
Stock-Based Compensation | 4,497 | 4,680 | 4,804 | 4,197 | 2,023 |
Provision & Write-off of Bad Debts | 410.83 | 567.02 | 382.18 | 307.96 | -322.96 |
Other Operating Activities | -532.11 | 732.87 | -593.22 | 32,954 | 42,325 |
Change in Accounts Receivable | -14,505 | -17,380 | -6,801 | -4,065 | -3,421 |
Change in Inventory | -9,311 | -7,074 | -761.34 | -928.29 | -923.6 |
Change in Accounts Payable | 1,846 | 2,317 | -402.64 | 335.18 | 1,272 |
Change in Other Net Operating Assets | -1,634 | 1,555 | -354.1 | -1,537 | -542.33 |
Operating Cash Flow | -38,587 | -34,740 | -27,664 | -24,723 | -17,881 |
Capital Expenditures | -7,564 | -7,233 | -4,345 | -2,298 | -654.24 |
Sale of Property, Plant & Equipment | -0 | 23.95 | - | 3.82 | - |
Sale (Purchase) of Intangibles | -544.43 | -489.6 | -110.01 | -196.15 | -311.12 |
Investment in Securities | -100,000 | -120,000 | 32,000 | -32,000 | - |
Other Investing Activities | -1,748 | -1,473 | -1,962 | -533.03 | -81.59 |
Investing Cash Flow | -109,857 | -129,173 | 26,442 | -35,023 | -1,095 |
Short-Term Debt Issued | - | 4,000 | - | - | 1,900 |
Total Debt Issued | 3,923 | 4,000 | - | - | 1,900 |
Short-Term Debt Repaid | - | -4,000 | - | -1,900 | - |
Long-Term Debt Repaid | - | -672.35 | -425.83 | -215.66 | -463.13 |
Total Debt Repaid | -4,751 | -4,672 | -425.83 | -2,116 | -463.13 |
Net Debt Issued (Repaid) | -828.5 | -672.35 | -425.83 | -2,116 | 1,437 |
Issuance of Common Stock | 132,515 | 159,115 | 10,596 | - | 28.13 |
Other Financing Activities | -0 | -0 | - | -0 | - |
Financing Cash Flow | 131,686 | 158,443 | 10,170 | 52,884 | 21,467 |
Foreign Exchange Rate Adjustments | 306.22 | 56.03 | -151.72 | -30.73 | -76.13 |
Miscellaneous Cash Flow Adjustments | - | - | -0 | - | -0 |
Net Cash Flow | -16,451 | -5,413 | 8,797 | -6,892 | 2,415 |
Free Cash Flow | -46,151 | -41,973 | -32,009 | -27,020 | -18,535 |
Free Cash Flow Margin | -89.22% | -81.99% | -118.02% | -156.49% | -191.52% |
Free Cash Flow Per Share | -2012.55 | -1890.19 | -1915.40 | -1906.97 | -1443.98 |
Cash Interest Paid | 875.33 | 823.12 | 702.89 | 656.03 | 150.91 |
Cash Income Tax Paid | - | -147.25 | 167.31 | 3.96 | 9.99 |
Levered Free Cash Flow | - | -34,480 | -168,238 | -57,828 | - |
Unlevered Free Cash Flow | - | -33,966 | -162,855 | -53,211 | - |
Change in Working Capital | -23,604 | -20,581 | -8,319 | -6,195 | -3,614 |